Search
for
Sort by
Research 91–120 of 1000+
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Baricitinib for alopecia areata
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Unraveling the secret life of the hair follicle: from fungi to innovative hair loss therapies
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- Medical Therapies
- 63-Year-Old Female with Diffuse Thinning of the Hair
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- What’s new in the treatment of hair loss?
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Ann Robinson’s research reviews —12 May 2022
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Janus Kinase inhibitors in dermatology: a review
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- The Role of Janus Kinase Inhibitors in Dermatology
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition